Please login to the form below

Not currently logged in
Email:
Password:

PPD rolls out microbiology services to Brussels and Singapore labs

Expansion provides upgraded testing for infectious diseases

Kentucky, US-headquartered contract research organisation (CRO) Pharmaceutical Product Development (PPD) has rolled out its microbiology testing services across its Belgium and Singapore facilities.

The expansion of the microbiology, peripheral blood mononuclear-cell and molecular-pathology services will enable the two international labs to test bacteriology, mycology, parasitology and microbioterrorism pathogens.

The Asian and European sites will be able to conduct virology testing, including real-time polymerase chain-reaction and viral-load tests, genotying and single nucleotide polymorphisms analyses.

In addition, both will now have the capabilities to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms.

"Adding these services to our Brussels and Singapore labs expands our ability to provide clients in Europe and Asia Pacific an important component of laboratory testing for infectious diseases," said Elena Logan, senior vice president of central labs for PPD.

"PPD is unique in that we offer fully integrated clinical trial management and central laboratory services, enabling us to provide increased efficiencies, greater study flexibility and added value to our clients."

12th February 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics